Radiation exposure to operating room personnel during transperineal interstitial permanent prostate brachytherapy.
OBJECTIVE
To identify factors associated with radiation exposure (RE) to operating room personnel during transperineal interstitial permanent prostate brachytherapy (TIPPB).


METHODS
Between May 1998 and December 2000, 155 patients underwent TIPPB with fluoroscopic and ultrasound guidance. Data for each case included: operating room time (OT), anesthesia time (AT), fluoroscopy time (FT), number and type of seed implanted, total seed activity, and resident participation.


RESULTS
Personnel RE per case, FT, OT, and AT decreased as case number increased. Whole body badge dose per case decreased from a mean of 0.15+/-0.01 mSv (15+/-1 mrem) in 1998 to 0.074+/-0.011 mSv (7+/-1 mrem) in 2000. Average FT per case decreased from a mean of 17:27 min (range, 10:40-28:23) in 1998 to 12:08 min (range, 6:40-31:00) in 2000. Resident participation was associated with increased FT. Mean whole body and ring badge doses for the treating radiation oncologist were 0.0076 mSv/min (0.76 mrem/min) and 0.05 mSv/min (5.26 mrem/min) of FT, respectively.


CONCLUSIONS
FT was the predominant factor that related to RE during TIPPB. Treating radiation oncologists were exposed to less than 20 mSv per 100 cases, significantly less than other fluoroscopically guided procedures. Nonetheless, appropriate radiation exposure precautions during TIPPB should continue.
Schwartz
David J
DJ
Division of Radiation Oncology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA.
Davis
Brian J
BJ
Vetter
Richard J
RJ
Pisansky
Thomas M
TM
Herman
Michael G
MG
Wilson
Torrence M
TM
LaJoie
Wayne N
WN
Oberg
Ann L
AL
D001822:Body Burden; D001918:Brachytherapy / Q000706:statistics & numerical data*; D005373:Film Dosimetry / Q000379:methods* / Q000706:statistics & numerical data*; D005471:Fluoroscopy / Q000706:statistics & numerical data*; D006801:Humans; D008297:Male; D016273:Occupational Exposure / Q000032:analysis*; D009873:Operating Rooms / Q000706:statistics & numerical data*; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011829:Radiation Dosage; D011835:Radiation Protection / Q000379:methods*; D018570:Risk Assessment / Q000379:methods*; D014915:Whole-Body Counting / Q000379:methods*